ZNF217 and breast carcinoma: Our previous work contributed to the demonstration that breast cancer cells possessing high ZNF217 expression levels display a more aggressive phenotype (e.g. increased cell proliferation, increased invasive properties and resistance to chemotherapy) (4, 5).